CYTK
Price
$48.55
Change
+$0.30 (+0.62%)
Updated
Sep 23 closing price
Capitalization
5.81B
36 days until earnings call
TTNP
Price
$4.21
Change
-$0.01 (-0.24%)
Updated
Sep 23 closing price
Capitalization
5.59M
Interact to see
Advertisement

CYTK vs TTNP

Header iconCYTK vs TTNP Comparison
Open Charts CYTK vs TTNPBanner chart's image
Cytokinetics
Price$48.55
Change+$0.30 (+0.62%)
Volume$1.9M
Capitalization5.81B
Titan Pharmaceuticals
Price$4.21
Change-$0.01 (-0.24%)
Volume$3.92K
Capitalization5.59M
CYTK vs TTNP Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. TTNP commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and TTNP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (CYTK: $48.55 vs. TTNP: $4.20)
Brand notoriety: CYTK and TTNP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 85% vs. TTNP: 7%
Market capitalization -- CYTK: $5.81B vs. TTNP: $5.59M
CYTK [@Biotechnology] is valued at $5.81B. TTNP’s [@Biotechnology] market capitalization is $5.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileTTNP’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • TTNP’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than TTNP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while TTNP’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 5 bearish.
  • TTNP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than TTNP.

Price Growth

CYTK (@Biotechnology) experienced а -2.43% price change this week, while TTNP (@Biotechnology) price change was -2.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.81B) has a higher market cap than TTNP($5.59M). TTNP YTD gains are higher at: 28.988 vs. CYTK (3.210). TTNP has higher annual earnings (EBITDA): -2.61M vs. CYTK (-504.83M). CYTK has more cash in the bank: 858M vs. TTNP (2.8M). TTNP has less debt than CYTK: TTNP (0) vs CYTK (858M). CYTK has higher revenues than TTNP: CYTK (85.7M) vs TTNP (0).
CYTKTTNPCYTK / TTNP
Capitalization5.81B5.59M103,843%
EBITDA-504.83M-2.61M19,342%
Gain YTD3.21028.98811%
P/E RatioN/AN/A-
Revenue85.7M0-
Total Cash858M2.8M30,610%
Total Debt858M0-
FUNDAMENTALS RATINGS
CYTK vs TTNP: Fundamental Ratings
CYTK
TTNP
OUTLOOK RATING
1..100
7785
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4163
P/E GROWTH RATING
1..100
174
SEASONALITY SCORE
1..100
7590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYTK's Valuation (100) in the Biotechnology industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew similarly to TTNP’s over the last 12 months.

CYTK's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew similarly to TTNP’s over the last 12 months.

TTNP's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as CYTK (100) in the Biotechnology industry. This means that TTNP’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Price Growth Rating (41) in the Biotechnology industry is in the same range as TTNP (63) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew similarly to TTNP’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for TTNP (74) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew significantly faster than TTNP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKTTNP
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DALN16.500.72
+4.56%
DallasNews Corp
TOL136.590.37
+0.27%
Toll Brothers
KTTA0.73N/A
N/A
Pasithea Therapeutics Corp
SA21.89-0.03
-0.14%
Seabridge Gold
TWI7.54-0.42
-5.28%
Titan International

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IONS. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+0.62%
IONS - CYTK
63%
Loosely correlated
+1.97%
MLYS - CYTK
53%
Loosely correlated
-2.91%
IMVT - CYTK
47%
Loosely correlated
-4.43%
NEVPF - CYTK
45%
Loosely correlated
N/A
CRNX - CYTK
45%
Loosely correlated
+6.35%
More

TTNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TTNP has been loosely correlated with INM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TTNP jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TTNP
1D Price
Change %
TTNP100%
-0.12%
INM - TTNP
44%
Loosely correlated
-5.73%
BPMUF - TTNP
27%
Poorly correlated
N/A
CYTK - TTNP
23%
Poorly correlated
+0.62%
VALN - TTNP
23%
Poorly correlated
-1.18%
GLTO - TTNP
23%
Poorly correlated
+40.67%
More